• Something wrong with this record ?

Phytocannabinoids and endocannabinoids

Z. Fišar

. 2009 ; 2 (1) : 51-75.

Language English Country United Arab Emirates

Document type Review, Research Support, Non-U.S. Gov't

Grant support
NR8408 MZ0 CEP Register

Progress in understanding the molecular mechanisms of cannabis action was made after discovery of cannabinoid receptors in the brain and the finding of endogenous metabolites with affinity to them. Activation of cannabinoid receptors on synaptic terminals results in regulation of ion channels, neurotransmitter release and synaptic plasticity. Neuromodulation of synapses by the cannabinoids is proving to have a wide range of functional effects, making them potential targets as medical preparations in a variety of illnesses, including some mental disorders and neurodegenerative illnesses. Cannabis contains a large amount of substances with affinity for the cannabinoid receptors. The endocannabinoids are a family of lipid neurotransmitters that engage the same membrane receptors targeted by tetrahydrocannabinol and that mediate retrograde signal from postsynaptic neurons to presynaptic ones. Discovery of endogenous cannabinoids and studies of the physiological functions of the cannabinoid system in the brain and body are producing a number of important findings about the role of membrane lipids and fatty acids in nerve signal transduction. Plant, endogenous and synthetic cannabinoids are using in these studies. The role of lipid membranes in the cannabinoid system follows from the fact that the source and supply of endogenous cannabinoids are derived from arachidonic acid, an important membrane constituent. The study of structure-activity relationships of molecules which influence the cannabinoid system in the brain and body is crucial in search of medical preparations with the therapeutic effects of the phytocannabinoids without the negative effects on cognitive function attributed to cannabis.

000      
03053naa 2200337 a 4500
001      
bmc11023027
003      
CZ-PrNML
005      
20180314105557.0
008      
110801s2009 ts e Eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ts
100    1_
$a Fišar, Zdeněk, $d 1956- $7 jn20000400692
245    10
$a Phytocannabinoids and endocannabinoids / $c Z. Fišar
314    __
$a Department of Psychiatry, 1st Faculty of Medicine, Charles University in Prague, Ke Karlovu 11, 128 01 Prague 2, Czech Republic. zfisar@lf1.cuni.cz
520    9_
$a Progress in understanding the molecular mechanisms of cannabis action was made after discovery of cannabinoid receptors in the brain and the finding of endogenous metabolites with affinity to them. Activation of cannabinoid receptors on synaptic terminals results in regulation of ion channels, neurotransmitter release and synaptic plasticity. Neuromodulation of synapses by the cannabinoids is proving to have a wide range of functional effects, making them potential targets as medical preparations in a variety of illnesses, including some mental disorders and neurodegenerative illnesses. Cannabis contains a large amount of substances with affinity for the cannabinoid receptors. The endocannabinoids are a family of lipid neurotransmitters that engage the same membrane receptors targeted by tetrahydrocannabinol and that mediate retrograde signal from postsynaptic neurons to presynaptic ones. Discovery of endogenous cannabinoids and studies of the physiological functions of the cannabinoid system in the brain and body are producing a number of important findings about the role of membrane lipids and fatty acids in nerve signal transduction. Plant, endogenous and synthetic cannabinoids are using in these studies. The role of lipid membranes in the cannabinoid system follows from the fact that the source and supply of endogenous cannabinoids are derived from arachidonic acid, an important membrane constituent. The study of structure-activity relationships of molecules which influence the cannabinoid system in the brain and body is crucial in search of medical preparations with the therapeutic effects of the phytocannabinoids without the negative effects on cognitive function attributed to cannabis.
590    __
$a bohemika - dle Pubmed
650    _2
$a zvířata $7 D000818
650    _2
$a kanabinoidy $x farmakologie $x chemie $7 D002186
650    _2
$a Cannabis $x chemie $7 D002188
650    _2
$a modulátory kanabinoidních receptorů $x metabolismus $7 D063385
650    _2
$a lidé $7 D006801
650    _2
$a léčivé rostliny $x chemie $7 D010946
650    _2
$a receptory kanabinoidní $x metabolismus $x účinky léků $7 D043882
650    _2
$a signální transdukce $x fyziologie $7 D015398
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
773    0_
$t Current Drug Abuse Reviews $w MED00194651 $g Roč. 2, č. 1 (2009), s. 51-75 $x 1874-4737
910    __
$a ABA008 $b x $y 2 $z 0
990    __
$a 20110802103539 $b ABA008
991    __
$a 20180314105607 $b ABA008
999    __
$a ok $b bmc $g 881876 $s 732956
BAS    __
$a 3
BMC    __
$a 2009 $b 2 $c 1 $d 51-75 $m Current drug abuse reviews $n Curr Drug Abuse Rev $i 1874-4737 $x MED00194651
GRA    __
$a NR8408 $p MZ0
LZP    __
$a 2011-4B09/jvme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...